A new study from the University of Oxford has revealed a surprising benefit of the respiratory syncytial virus (RSV) vaccine: ...

Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...

Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.

The "magic rods" are surgically implanted and can be slowly lengthened with internal and external magnets. It is a less invasive treatment than traditional methods involving body casts and surgeries.

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory ...

It is not clear how AS01 might help lower the risk of dementia, but Oxford University said lab studies show that the adjuvant ...

Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the recombinant shingles vaccine (Shingrix) -- were tied to a lower dementia risk, an ...

A new study shows that a vaccine against respiratory syncytial virus is associated with a 29% reduction in dementia risk in ...

A study published in NPJ Vaccines looks at adjuvants in vaccines and their association with a lower risk of dementia. Dr Julia Dudley, Head of Research at Alzheimer’s Research UK, said: ...